CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Thailand

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Thailand”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Thailand. It identifies the key trends in the healthcare market and provide insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Thailand. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

The Thailand pharmaceutical market is one of the growing markets in the South East Asian region. It was valued at $4.4B in 2012, which increased to $5.8B in 2017. It is forecast to reach $8.5B by 2024. The growing pharmaceutical market is attributed to the increasing non communicable diseases such as heart diseases, diabetes, stroke, and cancer; growth of aging population; universal health coverage leading to better access to healthcare services and expenditure on medicines; expansion of medical tourism industry and increasing number of foreign patients. In 2017, Thailand’s medical device market was worth $1.26B, which is estimated to reach $1.45B in 2020 with a CAGR of 4.87%.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in the Thailand, and includes:

• An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers

• Profiles and SWOT analyses of the major players in the pharmaceutical market (Pfizer, Novartis, GSK, Sanofi, and Jack Chia)

• Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Thailand

• An insightful review of the reimbursement and regulatory landscape, of which analysis include details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices

• Information regarding the health-tech landscape of the country

• Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure

• An overview of the opportunities and challenges to growth in the Thailand healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to:

• Develop business strategies by understanding the trends shaping and driving the Thailand healthcare market

• Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future

• Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors

• Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership

• Identify, understand, and capitalize on the opportunities and challenges in the Thailand healthcare market

Table of Contents

1 Table of Contents

1.1 List of Figures

1.2 List of Tables

2 Executive Summary

2.1 Executive Summary – Overview

2.2 Key Highlights

2.3 Key Highlights: Healthcare Start-Ups in Thailand

2.4 Key Events: Thailand Healthcare History, 2002–2019

2.5 Key Facts: Thailand Pharmaceutical Market

2.6 Key Events: M&A, VC & PE Deals, Global Pharmaceutical Market, 2018–2019

2.7 Key Events: Mergers and Acquisitions

2.8 Country Profile, Thailand, 2018

3 Overview of Pharmaceutical Market

3.1 Pharmaceutical Market – Overview

3.2 Pharmaceutical Market – Exports

3.3 Pharmaceutical Market – Imports

3.4 Pharmaceutical Market – Supply Channels

3.5 Pharmaceutical Market – Market Segments

3.6 Pharmaceutical Market – Major Therapeutic Areas

3.7 Pharmaceutical Market – Major Players

4 Overview of Medical Devices Market

4.1 Medical Device Market – Overview

4.2 Medical Device Market – Major Players

5 Pharmaceutical and Medical Device Market – Drivers and Barriers

5.1 Drivers

5.2 Barriers

6 Deal analysis

6.1 Deal Analysis: M&A, VF and PE Deals, Pharmaceutical Market, Thailand

7 HealthTech Landscape

7.1 HealthTech Landscape

7.2 Adoption of Technology in Healthcare, Thailand

7.3 Key Developments: Technology in Healthcare, Thailand

7.4 Regulatory Scenario Covering Use of Technology in Healthcare

7.5 HealthTech Landscape- Thailand- Benefits and Risks

8 Market Access

8.1 Overview of Healthcare System, Thailand

8.2 Reimbursement Process, Thailand

8.2.1 Overview of Public and Private Insurance Providers, Thailand

8.2.2 Healthcare Spending and Health Price Index, Thailand

8.2.3 Pricing Policies, Thailand

8.3 Regulatory Landscape, Thailand

8.3.1 Market Authorization of Medical Products, Thailand

8.3.2 Market Authorization of Medical Devices, Thailand

8.3.3 Intellectual Property Rights, Patent, Thailand

8.3.4 Intellectual Property Rights, Trademark, Thailand

8.3.5 Pharmaceutical Clinical Trials Landscape, Thailand

8.3.6 Medical Devices Clinical Trials Landscape, Thailand

8.3.7 Clinical Trial Regulations, Thailand

8.3.8 Exports and Imports Regulation, Thailand

8.3.9 Pharmaceutical Advertising Regulations, Thailand

8.3.10 Labeling and Packaging Regulations, Thailand

9 Country Healthcare Landscape

9.1 Thailand Healthcare Policy Highlights

9.2 Healthcare Facilities

9.3 Healthcare Parameters

9.4 Life Expectancy and Immunization Rate, Thailand

9.5 Environmental Health

9.6 Healthcare Personnel

9.7 Disease Burden

9.8 Healthcare Expenditure

10 Trade Associations, Thailand

11 Trade Fairs, Thailand

12 Opportunities and Challenges

13 Appendix

13.1 Research Methodology

13.1.1 Coverage

13.1.2 Secondary Research

13.1.3 Forecasts

13.1.4 Expert Panel

13.2 Bibliography

13.3 Contact Us

13.4 Disclaimer

List of Tables

Table 1: Major Therapeutic Area by Value of Drug Production and Imports (%), Thailand

Table 2: Fees for Pharmaceutical Products, Thailand

Table 2: Fees for Medical Devices, Thailand, 2018

Table 3: Patent Registration Fees, Thailand, 2019

Table 4: Patent Maintenance Fees, Thailand, 2019

Table 5: Trademark Fees, Thailand, 2019

Table 6: Label of a Pharmaceutical Unit Carton, Thailand

Table 7: Label of a Pharmaceutical Inner Label, Thailand

Table 8: Label of a Pharmaceutical Blister / Strips, Thailand

List of Figures

Figure 1: Pharmaceutical Market, Thailand, Revenue ($B), 2012–2019

Figure 2: Medical Device Market, Thailand, Revenue ($B), 2017–2020

Figure 3: Healthcare Startups in Thailand, Thailand, 2019

Figure 4: Number of Deals (2019–2020)

Figure 5: 2019–2020 Deal Overview By Region

Figure 6: Country Profile, Thailand, 2019

Figure 7: Pharmaceutical Market, Thailand, Revenue ($B), 2012–2019

Figure 8: Pharmaceutical Market, Thailand, Revenue Forecast ($B), 2020–2024

Figure 9: Pharmaceutical Market, Thailand, Pharmaceutical Exports ($B), 2011–2018

Figure 10: Pharmaceutical Market, Thailand, Top Export Partners, 2018

Figure 11: Pharmaceutical Market, Thailand, Pharmaceutical Imports,($B), 2011–2018

Figure 12: Pharmaceutical Market, Thailand, Top Import Partners, 2018

Figure 13: Pharmaceutical Market, Supply Chain, Thailand, 2019

Figure 14: Domestic Pharmaceutical Markets by Type, Thailand, 2018

Figure 15: List of Registered Generic Drugs, Thailand

Figure 16: List of Registered Biosimilars for Rheumatism, Thailand, 2019

Figure 17: OTC Market, UAE, Revenue ($B), 2011–2018

Figure 18: OTC Market by Drug Category, UAE, Revenue ($M), 2018

Figure 19: Major Therapeutic Area by Value of Drug Production and Imports (%), Thailand

Figure 20: Medical Device Market, Thailand, Revenue ($B), 2017–2020

Figure 21: Medical Device Market, Thailand, Revenue ($B) of Major Companies, 2019

Figure 22: Deal Value and Deal Count, Pharmaceutical Market, Thailand, 2019–2020

Figure 23: Deal Value and Deal Count Sub-Types, Pharmaceutical Market, Thailand, 2019–2020

Figure 24: M&A Deal Value and Deal Count Quarterly, Pharmaceutical Market, Thailand, 2019–2020

Figure 25: Need of Disruptive Innovation in Health Care Sector, Thailand, 2017

Figure 26: Overview of Healthcare System, Thailand, 2019

Figure 27: Addition to National List of Essential Medicine, Thailand

Figure 28: Health Insurance Coverage, Thailand, 2020

Figure 29: Health Insurance Schemes, Thailand, 2020

Figure 30: Health Financing Flow, Thailand, 2020

Figure 31: OOP Expenditure (% of total expenditure on health), Thailand, 2012–2016

Figure 32: Annual Rate of Change (%), Health Price Index, Thailand, 2012–2019

Figure 33: Pricing Policies, Thailand

Figure 34: Thailand FDA, Organizational Structure, Thailand, 2019

Figure 35: Bureau of Drug Control, Thailand, 2019

Figure 36: ASEAN Common Technical Requirements (ACTR), Thailand, 2019

Figure 37: Drug Registration and Approval Process, Thailand, 2017

Figure 38: Medical Devices Classification, Thailand, 2018

Figure 39: Medical Devices Premarketing Controls, Thailand, 2018

Figure 40: Patent Approval Process, Thailand, 2019

Figure 41: Trademark Approval Process, Thailand, 2019

Figure 42: Pharmaceutical Clinical Trials Count By Trial Status, Thailand, 2019–2020

Figure 43: Pharmaceutical Clinical Trials Count By Phase, Thailand, 2019–2020

Figure 44: Pharmaceutical Clinical Trials Count By Indication, Thailand, 2019–2020

Figure 45: Top Five Pharmaceutical Clinical Trials Sponsors By Count, Thailand,

Figure 46: Medical Devices Clinical Trials Count By Trial Status, Thailand, 2019–2020

Figure 47: Medical Devices Clinical Trials Count By Category, Thailand, 2019–2020

Figure 48: Medical Devices Clinical Trials Count By Indication, Thailand, 2019–2020

Figure 49: Top Five Medical Clinical Trials Sponsor By Count, Thailand, 2019–2020

Figure 50: Clinical Trial Requirements, Thailand

Figure 51: Pharmaceutical Advertising Approval Process, Thailand, 2017

Figure 52: Number of Hospitals, Thailand, 2011–2018

Figure 53: Number of Diagnostic Equipment, Thailand, 2011–2018

Figure 54: Public Hospital Beds, Thailand, 2011–2018

Figure 55: Private Hospital Beds, Thailand, 2011–2018

Figure 56: Hospital Beds Per Population, Thailand, 2011–2018

Figure 57: Life Expectancy, Thailand, 2011–2017

Figure 58: Immunization Rate (%), Thailand, 2011–2018

Figure 59: PM10 (µg per m3), Thailand, 2011–2017

Figure 60: CO2 Emissions (million tons), Thailand, 2011–2017

Figure 61: Physicians Per Population, Thailand, 2011–2018

Figure 62: Dentists Per Population, Thailand, 2011–2018

Figure 63: Pharmacists Per Population, Thailand, 2011–2018

Figure 64: Nurses Per Population, Thailand, 2011–2018

Figure 65: Major Causes of Mortality (number of deaths), Thailand, 2016

Figure 66: Major Causes of Male Mortality (number of deaths), Thailand, 2016

Figure 67: Major Causes of Female Mortality (number of deaths), Thailand, 2016

Figure 68: Disability-Adjusted Life Years by Major Disease (thousands), Thailand, 2016

Figure 69: Healthcare Expenditure as Percentage of GDP (%), Thailand,

Figure 70: Public–Private Share (%), Thailand, 2011–2016

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports